Evidence map›Paper›PMID 39187834›Full record

ArticleGlobalization and health2024

1-10-100: Unifying goals to mobilize global action on antimicrobial resistance.

Susan Rogers Van Katwyk, Mathieu J P Poirier, Sujith J Chandy, Kim Faure, Caitlin Fisher, Guillaume Lhermie, Arshnee Moodley, Satyajit Sarkar, Masika Sophie, Kayla Strong and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Globalization and health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Targeting Siderophore Biosynthesis to Thwart Microbial Growth.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Susan Rogers Van KatwykGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada.
Mathieu J P PoirierGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada. mathieu.poirier@globalstrategylab.org.
Sujith J ChandyInternational Centre for Antimicrobial Resistance Solutions (ICARS), Copenhagen, Denmark.
Kim FaureGlobal Antibiotic R&D Partnership, 1202, Geneva, Switzerland.
Caitlin FisherSchool of the Arts, Media, Performance, and Design, York University, Toronto, M3J 2S5, Canada.
Guillaume LhermieSchool of Public Policy, University of Calgary, Calgary, T2P 1H9, Canada.
Arshnee MoodleyDepartment of Veterinary and Animal Sciences, University of Copenhagen, 1870, Frederiksberg, Denmark.
Satyajit SarkarDepartment of Policy & Economic Research, International Vaccine Institute, Seoul, 08826, Korea.
Masika SophieWorld Federation for Animals, Boston, USA.
Kayla StrongGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada.
Isaac WeldonGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada.
Steven J HoffmanGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, York University, 4700 Keele Street, Dahdaleh Building 2120, Toronto, M3J 2S5, Canada.

Funding

Wellcome Trust 222422/Z/21/Z
6 · The paper itself

Abstract

The Bellagio Group for Accelerating AMR Action met in April 2024 to develop the ambitious but achievable 1-10-100 unifying goals to galvanize global policy change and investments for antimicrobial resistance mitigation: 1 Health; 10 million lives saved; and 100% sustainable access to effective antimicrobials. High profile political goals such as the Paris Agreement's objective to keep global warming well below 2° Celsius compared to pre-industrial levels, UNAIDS' 90-90-90 goal, and the Sustainable Development Goals challenge global norms, direct attention towards relevant activities, and serve an energizing function to motivate action over an extended period of time. The 1-10-100 unifying goals propose to unite the world through a One Health approach to safeguard human health, animal welfare, agrifood systems, and the environment from the emergence and spread of drug-resistant microbes and infections; save over 10 million lives by 2040 through concerted efforts to prevent and appropriately treat infections while preserving the vital systems and services that depend on sustained antimicrobial effectiveness; and commit to ensuring that antimicrobials are available and affordable for all, used prudently, and secured for the future through innovation. Compared to existing technical targets, these unifying goals offer advantages of focusing on prevention, encouraging multisectoral action and collaboration, promoting health equity, recognizing the need for innovation, and integrating with Sustainable Development Goals. By committing to 1 Health, 10 million lives saved, and 100% sustainable access to effective antimicrobials, we can protect lives and livelihoods today and safeguard options for tomorrow.

Indexed as

Global HealthDrug Resistance, MicrobialGoalsHumansAntimicrobial resistanceGlobal governanceOne healthSustainable development goalsUnifying goals

Identifiers

PMID39187834
PMCPMC11348599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.